STERIS plc (NYSE: STE) shares surged 5.05% in after-hours trading on Wednesday following the release of its fiscal 2025 fourth-quarter results, which exceeded analyst expectations. The medical equipment company reported strong financial performance and provided an optimistic outlook for the coming fiscal year.
For the fourth quarter, STERIS posted adjusted earnings per share of $2.74, significantly beating the FactSet consensus estimate of $2.59. This represents a 13.69% increase from the same period last year. The company's quarterly revenue also surpassed expectations, coming in at $1.48 billion compared to the estimated $1.47 billion, marking a 4.37% year-over-year growth.
The strong quarterly performance capped off a successful fiscal year 2025 for STERIS. The company reported a 6% increase in full-year revenue, reaching $5.5 billion, with constant currency organic revenue growth also at 6%. STERIS's Healthcare segment saw a 5% revenue growth, while the Applied Sterilization Technologies segment reported an impressive 9% increase. Looking ahead, STERIS provided a positive outlook for fiscal 2026, projecting adjusted earnings per share from continuing operations in the range of $9.90 to $10.15. This optimistic forecast, coupled with the robust Q4 results, likely contributed to the stock's after-hours rally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.